Partner with JPT

JPT Peptide Technologies is an ISO 9001:2015 certified and GCLP compliant innovative service provider and research & development partner.

JPT’s proprietary peptide technologies help to advance projects for a variety of applications such as

  • Development of vaccines and immunotherapies
  • Immune monitoring and diagnostic content research
  • Seromarker discovery and validation
  • Vaccine target and epitope discovery peptide lead discovery and systematic peptide optimization
  • Discovery, clinical and functional proteomics 

  Immunotherapy & Vaccines   Drug Discovery & Optimization      Proteomics     

Why partner with JPT?

JPT is the preferred partner for peptide related projects because of its:
  • Proprietary technologies for peptide synthesis and high throughput screening
  • Integrated in-house R&D team for organic and medicinal chemistry, immunology and assay development, structural biology, bioinformatics and data management
  • Solid track record of successful R&D projects
  • Flexible business arrangements for collaborative projects
  • ISO 9001:2015 and GCLP regulated quality assurance system
  • Professional project management and communication

What do we offer?

JPT offers its services and contract research and development project participation in flexible business arrangements.

Our Business Models are:
  • Fee-for-service projects
  • FTE based and milestone driven collaboration projects
  • Shared risk, partnered development projects
  • Participation on publicly granted R&D projects

Project Partners

  • ARBF (Association of Biomolecular Resource Facilities)
  • Bayer Pharma AG
  • BioNTech AG
  • Brighton & Sussex Medical School
  • Cancer Immunotherapy Trials Network (CITN)
  • Charité Universitätsmedizin Berlin
  • CPRG (Centre for Proteomic & Genomic Research)
  • Epiontis
  • Friedrich-Loeffler-Institut
  • Harvard Medical School
  • Immudex
  • Pfizer Research & Development
  • Technical University of Munich (TUM)
  • Thermo Fisher Scientific
  • SAP
  • QIMR Berghofer
  • Yale University
  • Zellnet
and various undisclosed partners

Track record

JPT has run several successful projects in different scientific fields:

Immunotherapy & Vaccines
  • Peptide selection and synthesis for individualized neo-epitope based vaccination strategies
  • Peptide pool design and synthesis for adoptive cell transfer therapy
  • Design of comprehensive peptide libraries for companion diagnostics and treatment
  • Identification of serological predictive, prognostic, and surrogate biomarkers
  • Proteome-spanning vaccine target discovery
  • Deep T-cell epitope discovery


  • Development of next generation standards for targeted proteomics
  • Characterization of specificity profiles for proteins and protein families
  • Design and synthesis of peptide libraries for proteome wide detection and quantification of proteins
  • Development of molecular probes for the multiplexed detection and quantification of proteins from biological samples
  • Discovery of proteotypic peptide markers for functional proteomics
  • Identification of epigenetic states of proteins and characterization of enzymatic alterations

Drug Discovery

  • Design and production of screening libraries, peptides and peptidomimetics
  • Identification and optimization of agonistic and antagonistic ligands
  • Identification and optimization of affinity ligands
  • Identification and optimization of stabilizing peptides as excipients
  • Development of surrogate bioassays for antigen-free detection of therapeutic protein
  • Substrate identification and optimization for several orphan enzymes for screening assays

Check our list of products, click and go.

Get a quote